TFX Teleflex Incorporated

Teleflex Announces Quarterly Dividend

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2017 to shareholders of record at the close of business on March 3, 2017.

The company offers a Dividend Reinvestment & Direct Stock Purchase and Sale Plan. For information about the Plan, call 1-877-842-1572 (toll free), or log on to www.amstock.com to make an initial purchase. Additional information about Teleflex can be obtained from the company’s website at www.teleflex.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose.

EN
23/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teleflex Incorporated

Teleflex Incorporated - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Teleflex Incorporated: Update following revision of outlook to stable

Our credit view of this issuer reflects its very good liquidity and strong free cash flow, constrained by its highly competitive industry sector.

Teleflex Incorporated - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's Ratings revises Teleflex's outlook to stable, affirms Ba1 CFR,...

Moody's Ratings (Moody's) affirmed the ratings of Teleflex Incorporated ("Teleflex") including the Ba1 Corporate Family Rating (CFR), Ba1-PD Probability of Default Rating (PDR) and the Ba2 rating on the senior unsecured notes. The company's Speculative Grade Liquidity Rating (SGL) was unchanged at S...

 PRESS RELEASE

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM...

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion Board of Directors authorizes new $1 billion share repurchase program WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the company’s Acute Care, Interventional Urology and OEM businesses to two buyers, Intersurgical® Ltd with respect to Acute Care and Interventional Urology, and Montagu and Kohlberg with respect to OEM, for a combined total of...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch